Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiromu Habashita

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|September 6, 2002
Novel and potent anti-malarial agentsKristin M Brinner, Jin Mi Kim, Hiromu Habashita, et al.
Bioorganic & Medicinal Chemistry|February 17, 2006
Discovery of a new chemical lead for a matrix metalloproteinase inhibitorMasahiro Ikura, Shingo Nakatani, Shingo Yamamoto, et al.
European Journal of Pharmacology|October 22, 2013
Suppressive effects of a novel CC chemokine receptor 4 antagonist on Th2 cell trafficking in ligand- and antigen-induced mouse modelsTakaki Komiya, Tetsuya Sugiyama, Kazuhiko Takeda, et al.
Bioorganic & Medicinal Chemistry|March 12, 2002
Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing studyHirokazu Tamamura, Akane Omagari, Kenichi Hiramatsu, et al.
The Journal of Organic Chemistry|May 2, 1997
Palladium(0)-Catalyzed Isomerization Reactions of Aziridines Bearing an alpha,beta-Unsaturated Ester Group: A Thermodynamic Preference for Chiral Alkyl (2E)-4,5-cis-4,5-Epimino-N-(alkyl- or arylsulfonyl) 2-Enoates over the Other Three StereoisomersToshiro Ibuka, Norio Mimura, Hiroaki Ohno, et al.
Bioorganic & Medicinal Chemistry|May 24, 2005
Novel matrix metalloproteinase inhibitors: generation of lead compounds by the in silico fragment-based approachKanji Takahashi, Masahiro Ikura, Hiromu Habashita, et al.
Journal of Medicinal Chemistry|July 11, 2006
Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonistsHiromu Habashita, Masaya Kokubo, Shin-ichi Hamano, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Design and synthesis of novel metalloproteinase inhibitorsShingo Nakatani, Masahiro Ikura, Shingo Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Structure-activity relationship studies of sphingosine-1-phosphate receptor agonists with N-cinnamyl-β-alanine moietyHaruto Kurata, Kazuhiro Otsuki, Kensuke Kusumi, et al.
ACS Medicinal Chemistry Letters|October 25, 2016
Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to LeadMasahiko Terakado, Hidehiro Suzuki, Kazuya Hashimura, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|September 6, 2002
Novel and potent anti-malarial agentsKristin M Brinner, Jin Mi Kim, Hiromu Habashita, et al.
Bioorganic & Medicinal Chemistry|February 17, 2006
Discovery of a new chemical lead for a matrix metalloproteinase inhibitorMasahiro Ikura, Shingo Nakatani, Shingo Yamamoto, et al.
European Journal of Pharmacology|October 22, 2013
Suppressive effects of a novel CC chemokine receptor 4 antagonist on Th2 cell trafficking in ligand- and antigen-induced mouse modelsTakaki Komiya, Tetsuya Sugiyama, Kazuhiko Takeda, et al.
Bioorganic & Medicinal Chemistry|March 12, 2002
Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing studyHirokazu Tamamura, Akane Omagari, Kenichi Hiramatsu, et al.
The Journal of Organic Chemistry|May 2, 1997
Palladium(0)-Catalyzed Isomerization Reactions of Aziridines Bearing an alpha,beta-Unsaturated Ester Group: A Thermodynamic Preference for Chiral Alkyl (2E)-4,5-cis-4,5-Epimino-N-(alkyl- or arylsulfonyl) 2-Enoates over the Other Three StereoisomersToshiro Ibuka, Norio Mimura, Hiroaki Ohno, et al.
Bioorganic & Medicinal Chemistry|May 24, 2005
Novel matrix metalloproteinase inhibitors: generation of lead compounds by the in silico fragment-based approachKanji Takahashi, Masahiro Ikura, Hiromu Habashita, et al.
Journal of Medicinal Chemistry|July 11, 2006
Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonistsHiromu Habashita, Masaya Kokubo, Shin-ichi Hamano, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Design and synthesis of novel metalloproteinase inhibitorsShingo Nakatani, Masahiro Ikura, Shingo Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Structure-activity relationship studies of sphingosine-1-phosphate receptor agonists with N-cinnamyl-β-alanine moietyHaruto Kurata, Kazuhiro Otsuki, Kensuke Kusumi, et al.
ACS Medicinal Chemistry Letters|October 25, 2016
Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to LeadMasahiko Terakado, Hidehiro Suzuki, Kazuya Hashimura, et al.
Pageof 2